Evaluation of cervical cancer screening programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV status

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Anderson, Jean ^a   Wysong, Megan ^b   Estep, Deb ^b   Besana, Giulia ^b   Kibwana, Sharon ^b   Varallo, John ^b   Sun, Kai ^a   Lu, Enriquito ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CRYOTHERAPY; FEMALE; HEALTH CARE FACILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; RURAL AREA; SCREENING TEST; TANZANIA; TREATMENT RESPONSE; URBAN AREA; UTERINE CERVIX CANCER; COMPLICATION; COTE D'IVOIRE; EARLY CANCER DIAGNOSIS; GUYANA; HIV INFECTIONS; MULTIVARIATE ANALYSIS; PROCEDURES; STATISTICAL MODEL; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

COTE D'IVOIRE; EARLY DETECTION OF CANCER; FEMALE; GUYANA; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; TANZANIA; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84947239888     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139242     Document Type: Article

References (36)

1. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, et al. Prevalence, incidence, and typespecific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIVnegative women. J Infect Dis. 2001; 184: 682-690. PMID: 11517428
2. De Vuyst H, Mugo NR, Chung MH, McKenzie KP, Nyongesa-Malava E, Njoroge JW, et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer. 2012; 107: 1624-1630. doi: 10.1038/bjc.2012.441 PMID: 23033006
3. International Agency for Research on Cancer (IARC), World Health Organization. Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012 [cited 8 August 2014]. In IARC Fact Sheets. Lyon, France. Available: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx.
4. UNAIDS. UNAIDS Report on the Global AIDS Epidemic 2012 [cited 3 September 2013]. Geneva: UNAIDS/WHO. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120-UNAIDS-Global-Report-2012-with-annexes-en.pdf.
5. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998; 92: 727-735. PMID: 9764690
6. Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990; 113: 214-226. PMID: 2115753
7. Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008; 16: 41-49. doi: 10.1016/S0968-8080(08)32415-X PMID: 19027621
8. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K, Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO Corporation Cervical Cancer Prevention Group. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet. 2003; 361: 814-820. PMID: 12642047
9. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007; 370: 398-406. PMID: 17679017
10. Plotkin M, Besana GV, Yuma S, Kim YM, Kulindwa Y, Kabole F, et al. Integrating HIV testing into cervical cancer screening in Tanzania: an analysis of routine service delivery statistics. BMC Women's Health. 2014; 14:120. doi: 10.1186/1472-6874-14-120 PMID: 25271025
11. Cervical Cancer Action (CCA). Progress in Cervical Cancer Prevention: The CCA Report Card; 2012 [cited 3 September 2013]. Available: http://www.cervicalcanceraction.org/pubs/CCA-reportcard-lowres.pdf.
12. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [cited 15 August 2014]. Lyon, France: International Agency for Research on Cancer. Available: http://globocan.iarc.fr.
13. Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Touré-Coulibaly K, Maurice C, Vernon SD, et al. Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis. 2010; 10: 242. doi: 10.1186/1471-2334-10-242 PMID: 20716343
14. Kahesa C, Mwaiselage J, Wabinga HR, Ngoma T, Kalyango JN, Karamagi CA. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BMC Public Health. 2008; 8: 262. doi: 10.1186/1471-2458-8-262 PMID: 18664298
15. Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenbern L, et al. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer. 2006; 6: 135. PMID: 16719902
16. UNAIDS. Regions and Countries. Available: http://www.unaids.org/en/regionscountries.
17. Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Olshan A, et al. Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis. 2013; 57:756-764. doi: 10.1093/cid/cit369 PMID: 23735330
18. Atashili J, Smith JS, Adimora AA, Eron J, Miller WC, Myers E. Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation. PLoS One. 2011; 6(4): e18527. doi: 10.1371/journal.pone.0018527 PMID: 21483701
19. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2): 74-108. PMID: 15761078
20. Ashraf H. Poor nations need more help to slow growing cancer burden: the International Atomic Energy Agency asks donors to provide millions of dollars to buy radiotherapy equipment. Lancet. 2003; 361: 2209. PMID: 12842403
21. Cronje HS. Screening for cervical cancer in developing countries. Int J Gynaecol Obstet. 2004; 84: 101-108. PMID: 14871510
22. Phongsavan K, Phengsavanh A, Wahlstrom R, Marions L. Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos. Int J Gynaecol Obstet. 2011; 114: 268-272. doi: 10.1016/j.ijgo.2011.03.009 PMID: 21752376
23. Sanghvi H, Limpaphayom KK, Plotkin M, Charurat E, Kleine A, Lu E, et al. Cervical cancer screening using visual inspection with acetic acid: operational experiences from Ghana and Thailand. Reprod Health Matters. 2008; 16: 67-77. doi: 10.1016/S0968-8080(08)32401-X PMID: 19027624
24. Sherigar B, Dalal A, Durdi G, Pujar Y, Dhumale H. Cervical cancer screening by visual inspection with acetic acid-interobserver variability between nurse and physician. Asian Pac J Cancer Prev. 2010; 11:619-622. PMID: 21039026
25. Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet. 2011; 113: 14-24. doi: 10.1016/j. ijgo.2010.10.012 PMID: 21257169
26. World Health Organization (WHO). A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia. World Health Organization, Geneva, Switzerland; 2012.
27. Firnhaber C, Mayisela N, Mao L, Williams S, Swarts A, Faesen M, et al. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One. 2013; 8(1): e53494. doi: 10.1371/journal.pone.0053494 PMID: 23326441
28. Joshi S, Sankaranarayanan R, Muwonge R, Kulkarni V, Somanathan T, Divate U. Screening of cervical neoplasia in HIV-infected women in India. AIDS. 2013; 27:607-15. doi: 10.1097/QAD. 0b013e32835b1041 PMID: 23079814
29. Ramogola-Masire D, de Klerk R, Monare B, Ratshaa B, Friedman HM, Zetola NM. x Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana. J Acquir Immune Defic Syndr Hum Retrovirol. 2012; 59: 308-313.
30. Huchko MJ, Bukusi EA, Cohen CR. Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. Int J Gynaecol Obstet. 2011; 114:106-110. doi: 10.1016/j.ijgo.2011.02.009 PMID: 21620403
31. Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, et al. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screenand-treat' program integrated with HIV/AIDS care in Zambia. PLoS One. 2013; 18; 8(9):e74607. doi: 10.1371/journal.pone.0074607 PMID: 24058599
32. Horo A, Jaquet A, Ekouevi DK, Toure B, Coffie PA, Effi B, et al. IeDEA West Africa Collaboration. Cervical cancer screening by visual inspection in Côte d'Ivoire, operational and clinical aspects according to HIV status. BMC Public Health. 2012; 12:237. doi: 10.1186/1471-2458-12-237 PMID: 22443255
33. Khozaim K, Orang'o E, Christoffersen-Deb A, Itsura P, Oguda J, Muliro H, et al. Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya. Int J Gynaecol Obstet. 2014; 124:12-8. doi: 10.1016/j.ijgo.2013.06.035 PMID: 24140218
34. Kupets R, Paszat L. (2011) Physician and patient factors associated with follow up of high grade dysplasias of the cervix: a population-based study. Gynecol Oncol. 2011; 120: 63-67. doi: 10.1016/j. ygyno.2010.09.011 PMID: 20940073
35. Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst. 2010; 102: 1557-1567. doi: 10.1093/jnci/djq342 PMID: 20884893
36. WHO. Global Health Sector Strategy on HIV/AIDS 2011-2015. Geneva: WHO; 2011.